Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
Clinical trial NCT04055909 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04055909
- Sponsor
- Inotrem
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2022-05-09
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.